TY - JOUR
T1 - Cell-based therapy for chronic obstructive pulmonary disease rebuilding the lung
AU - Weiss, Daniel J.
N1 - Publisher Copyright:
Copyright © 2018 by the American Thoracic Society.
PY - 2018/12
Y1 - 2018/12
N2 - As the prevalence and impact of lung diseases continue to increase worldwide, new therapeutic strategies are desperately needed. Advances in lung-regenerative medicine, a broad field encompassing stem cells, cell-based therapies, and a range of bioengineering approaches, offer new insights into and new techniques for studying lung physiology and pathophysiology. This provides a platform for the development of novel therapeutic approaches. Applicability to chronic obstructive pulmonary disease of recent advances and applications in cell-based therapies, predominantly those with mesenchymal stromal cell-based approaches, and bioengineering approaches for lung diseases are reviewed.
AB - As the prevalence and impact of lung diseases continue to increase worldwide, new therapeutic strategies are desperately needed. Advances in lung-regenerative medicine, a broad field encompassing stem cells, cell-based therapies, and a range of bioengineering approaches, offer new insights into and new techniques for studying lung physiology and pathophysiology. This provides a platform for the development of novel therapeutic approaches. Applicability to chronic obstructive pulmonary disease of recent advances and applications in cell-based therapies, predominantly those with mesenchymal stromal cell-based approaches, and bioengineering approaches for lung diseases are reviewed.
KW - Bioengineering
KW - Cell therapy
KW - Mesenchymal stromal cell
UR - http://www.scopus.com/inward/record.url?scp=85058780111&partnerID=8YFLogxK
U2 - 10.1513/AnnalsATS.201808-534MG
DO - 10.1513/AnnalsATS.201808-534MG
M3 - Artículo
C2 - 30759002
AN - SCOPUS:85058780111
SN - 2325-6621
VL - 15
SP - S253-S259
JO - Annals of the American Thoracic Society
JF - Annals of the American Thoracic Society
ER -